COMMUNIQUÉS West-GlobeNewswire

Roche’s Tecentriq plus platinum-based chemotherapy reduced the risk of disease worsening or death in people with previously untreated advanced bladder cancer
05/08/2019
IMvigor130 is the first positive Phase III study of a cancer immunotherapy combination in previously untreated advanced bladder cancer Data will be shared with health authorities globally, including the U.S. Food and [...]
Telix Pharmaceuticals and German Cancer Research Center (DKFZ) Enter into Collaboration and Option Agreement for Image-Guided Prostate Surgery
05/08/2019
MELBOURNE, Australia and HEIDELBERG, Germany, Aug. 05, 2019 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX.TLX) (“Telix”, the “Company”), a clinical-stage biopharmaceutical company focused on the development of [...]
Oasmia intends to delist from NASDAQ in the US to reduce complexity and costs
03/08/2019
Oasmia Pharmaceutical AB (“Oasmia” or the “Company”) announced today that it intends to delist its American Depositary Shares (“ADS”) from the Nasdaq Capital Market (“NASDAQ”) and to deregister and terminate its [...]
Ownership and Transfer of Shares of Vibe Bioscience Ltd.
03/08/2019
This press release is issued pursuant to Multilateral Instrument 62-104 – Take-Over Bids and Issuer Bids and National Instrument 62-103 – The Early Warning System and Related Take-Over Bid and Insider Reporting Issues [...]
Flexion Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/08/2019
BURLINGTON, Mass., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced equity inducement grants to 11 new employees consisting of an aggregate of 68,650 stock options and 11,525 [...]
Xeris Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
02/08/2019
CHICAGO, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable [...]
Tonix Pharmaceuticals Announces Director Stepping Down
02/08/2019
NEW YORK, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix) announced that Patrick Grace stepped down from the Company’s Board of Directors, effective August 1, 2019. Mr. Grace [...]
Marrone Bio Innovations to Report Second Quarter 2019 Results on Thursday, August 8th at 4:30 p.m. Eastern Time
02/08/2019
DAVIS, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Marrone Bio Innovations Inc. (NASDAQ: MBII) (MBI), a leading developer of bio-based products for pest management and plant health, will release financial results for the [...]
Alphatec Holdings, Inc. Announces Closing of Public Stock Offering and Full Exercise of Underwriters’ Option to Purchase Additional Stock
02/08/2019
CARLSBAD, Calif., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Alphatec Holdings, Inc. (“ATEC”) (NASDAQ: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, today [...]
Alder BioPharmaceuticals® Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
02/08/2019
BOTHELL, Wash., Aug. 02, 2019 (GLOBE NEWSWIRE) -- Alder BioPharmaceuticals, Inc. (Nasdaq: ALDR), a biopharmaceutical company focused on developing novel therapeutic antibodies for the treatment of migraine, today [...]
Skin Care & Laser Physicians of Beverly Hills Expands Physician Availability for Patients
02/08/2019
Board-certified dermatologist Dr. Ardalan Minokadeh joined the Los Angeles-area team full time in May BEVERLY HILLS, Cal., Aug. 02, 2019 (GLOBE NEWSWIRE) -- The Skin Care & Laser Physicians of Beverly Hills team [...]
Arcturus Therapeutics Announces $2.3 Million Additional Registered Direct Offering of Common Stock
02/08/2019
SAN DIEGO, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Arcturus Therapeutics (“Arcturus” or the “Company”), a leading RNA medicines company focused on the discovery, development and commercialization of therapeutics for rare [...]
Resverlogix Announces Loan Reduction and Extension
02/08/2019
Loan reduced from US$30 million to US$11.5 million CALGARY, Alberta, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the "Company") (TSX: RVX) today announces that it has entered into an amending [...]
Information relative au nombre total de droits de vote et d’actions composant le capital social au 31 juillet 2019
02/08/2019
Paris, le 2 août 2019 – 18 :00 CET - Pixium Vision (FR0011950641 - PIX), société bioélectronique qui développe des systèmes de vision bionique innovants pour permettre aux patients ayant perdu la vue, de vivre de façon [...]
Information on total number of voting rights and shares composing the share capital as at July 31st, 2019
02/08/2019
Paris, August 2 nd , 2019 – 6.00PM CET - Pixium Vision (FR0011950641 - PIX), a bioelectronic company developing innovative bionic vision systems to allow patients who have lost their sight to lead more independent lives [...]
Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2019
02/08/2019
Article 223-16 of general regulation of French Autorité des Marchés Financiers Lyon – France LYON, France, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Listing markets: Euronext Paris from Euronext (Market segment C - ISIN Code: [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 Juillet 2019
02/08/2019
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers Lyon - France LYON, France, 02 août 2019 (GLOBE NEWSWIRE) -- Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : [...]
Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2019
02/08/2019
Monthly information related to total number of voting rights and shares composing the share capital – July 31, 2019 LYON, France, Aug. 02, 2019 (GLOBE NEWSWIRE) -- Listing markets: Euronext Paris from Euronext (Market [...]
Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital social – 31 Juillet 2019
02/08/2019
Article 223-16 du Règlement Général de l’Autorité des Marchés Financiers LYON, France, 02 août 2019 (GLOBE NEWSWIRE) -- Places de cotation : Euronext Paris de Euronext (Compartiment C - Code ISIN : FR0011471135 – [...]

Pages